LP pro kardiovaskulární systém XX. - Evolocumab
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 28208424 | 12. 09. 2024 | Amgen s.r.o. | 40 432 000,00 | 36 100 000,00 | 40 432 000,00 | 36 100 000,00 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| 617_Pisemna_zprava.pdf_podepsano.pdf | Písemná zpráva zadavatele | 01. 10. 2024 11:01 | Dokument není zavirovaný |
List of Participants
| Show detail | ||||||
|---|---|---|---|---|---|---|
| Amgen s.r.o. | Praha | 40 428 460,80 | 36 096 840,00 | CZK | Yes |